NCT06931678

Brief Summary

This clinical study investigates the effectiveness of antimicrobial photodynamic therapy (aPDT) as an additional disinfection method in root canal treatment of patients with Type 2 Diabetes Mellitus (T2DM) who have apical periodontitis (AP). T2DM is known to negatively impact the healing of periapical tissues due to impaired immune response. In this study, methylene blue is used as a photosensitizer, activated by a specific wavelength of light to eliminate residual bacteria that are difficult to reach with conventional cleaning methods. The bacterial load and changes in the root canal microbiome will be analyzed using next-generation sequencing (NGS) of the 16S rRNA gene. The goal is to assess the microbial elimination and healing of periapical lesions, and to improve treatment outcomes in diabetic patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 21, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 7, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 7, 2025

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 8, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 17, 2025

Completed
Last Updated

April 17, 2025

Status Verified

April 1, 2025

Enrollment Period

6 months

First QC Date

April 8, 2025

Last Update Submit

April 16, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • 1. Radiographic Assessment of Lesion Healing at 6 months

    Lesion healing will be evaluated using periapical radiographs with the parallel technique, and the Periapical Index (PAI) will be used for the assessment of lesion healing.

    Postoperative an avarage of 6 months

  • Change in Pain Level at day 1, day 3, and day 7 Post-Treatment

    Pain levels will be assessed using the Numerical Rating Scale (NRS), ranging from 0 (no pain) to 100 (worst pain), measured at day 1, day 3, and day 7 post-procedure.

    Post-Treatment at day 1, day 3, and day 7

Other Outcomes (1)

  • Microbiome analysis

    Posttreatment an average on 3 months

Study Arms (1)

Necrotic pulped, mature teeth with apical periodontitis

EXPERIMENTAL

This study arm involves the application of antimicrobial photodynamic therapy (aPDT) as an adjunct to conventional root canal treatment in mature permanent teeth diagnosed with apical periodontitis and pulp necrosis. Following standard chemomechanical preparation, methylene blue is used as the photosensitizer, activated by a specific wavelength light source to enhance disinfection of the root canal system.

Procedure: aPDT

Interventions

aPDTPROCEDURE

This intervention involves the application of antimicrobial photodynamic therapy (aPDT) using methylene blue as a photosensitizer, followed by activation with a light source at an appropriate wavelength. The protocol is applied after conventional root canal preparation and irrigation. The aPDT protocol is standardized and performed in both medically healthy patients and patients with Type 2 Diabetes Mellitus (T2DM), allowing comparison of microbiological and clinical outcomes between the two groups. This intervention aims to enhance root canal disinfection, particularly in anatomically complex areas that are difficult to reach with traditional methods.

Necrotic pulped, mature teeth with apical periodontitis

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals aged between 18 and 65 years
  • Voluntarily agree to participate in the study and attend follow-up sessions
  • Systemically healthy individuals (no systemic diseases)
  • Not taking antihypertensive or antidiabetic medications
  • Not pregnant
  • No use of corticosteroids or antibiotics within the last 3 months
  • No history of smoking
  • No acute pain or extraoral swelling
  • No sinus tract or acute apical abscess
  • Presence of a periapical lesion with a Periapical Index (PAI) score ≥ 3
  • Presence of a mature, single-rooted permanent tooth with completed root development

You may not qualify if:

  • Severe periodontal disease
  • Internal or external root resorption
  • Open apex (immature root development)
  • Suspected vertical root fracture
  • Non-restorable teeth
  • Teeth with previous root canal treatment
  • Presence of developmental dental anomalies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gulhane Faculty of Dentistry, University of Health Sciences

Ankara, Etlik, 06010, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Dental Pulp NecrosisPeriapical Periodontitis

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesDental Pulp DiseasesTooth DiseasesStomatognathic DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and SymptomsPeriapical DiseasesJaw DiseasesPeriodontal DiseasesMouth DiseasesPeriodontitis

Study Officials

  • Hulde Korucu, DDS

    University of Health Sciences Gülhane Faculty of Dentistry Department of Endodontics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2025

First Posted

April 17, 2025

Study Start

October 21, 2024

Primary Completion

April 7, 2025

Study Completion

April 7, 2025

Last Updated

April 17, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

The impact of gender differences on pain assessment in the study was also evaluated. Additionally, the effect of age on lesion healing was analyzed. Since the study examines the effects of demographic data on lesion healing and post-treatment pain, demographic data will be shared.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
The IPD and supporting information will be available for 2 years following the treatment outcomes.

Locations